Mallinckrodt and Endo , drugmakers with a shared history of facing U.S. opioid litigation, have agreed to merge in a deal ...
Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...
Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the ...
Mallinckrodt and Endo, drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced ...
KEY TAKEAWAYS Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on ...
The bill (LB168) from Sen. Brian Hardin of Gering would prohibit drugmakers from restricting the sale of medications included ...
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...
Seeking Alpha on MSN10d
Generic drugmakers could see negative impact from higher Chinese tariffsTrump's tariff hike on Chinese goods may tighten margins for generic drugmakers relying on Chinese APIs. Read more here.
Generic drugmakers could be significantly impacted by President Trump's decision to double the tariff on Chinese goods to 20% as a portion of active pharmaceutical ingredients (APIs) used in ...
Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. "It's about the size of a small ...
Learn how hospitals are cutting costs by buying directly from pharmaceutical companies, as drug prices continue to rise and impact operating losses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback